Miura S - Search Results

1

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events.

Fujisaki T, Watanabe S, Ota T, Kushiro K, Sato Y, Takahashi M, Ohtsubo A, Shoji S, Nozaki K, Ichikawa K, Hokari S, Kondo R, Miyabayashi T, Abe T, Miura S, Tanaka H, Okajima M, Terada M, Matsumoto N, Ishida T, Iwashima A, Sato K, Yoshizawa H, Aoki N, Hayashi M, Ohshima Y, Koya T, Kikuchi T. Fujisaki T, et al. Among authors: miura s. Front Oncol. 2021 Sep 24;11:704475. doi: 10.3389/fonc.2021.704475. eCollection 2021. Front Oncol. 2021. PMID: 34631533 Free PMC article.

2

Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.

Hiura T, Kagamu H, Miura S, Ishida A, Tanaka H, Tanaka J, Gejyo F, Yoshizawa H. Hiura T, et al. Among authors: miura s. J Immunol. 2005 Oct 15;175(8):5058-66. doi: 10.4049/jimmunol.175.8.5058. J Immunol. 2005. PMID: 16210609

3

Generation of anti-tumour effector T cells from naïve T cells by stimulation with dendritic/tumour fusion cells.

Ishida A, Tanaka H, Hiura T, Miura S, Watanabe S, Matsuyama K, Kuriyama H, Tanaka J, Kagamu H, Gejyo F, Yoshizawa H. Ishida A, et al. Among authors: miura s. Scand J Immunol. 2007 Nov;66(5):546-54. doi: 10.1111/j.1365-3083.2007.02012.x. Scand J Immunol. 2007. PMID: 17953530 Free article.

4

Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity.

Miura S, Kagamu H, Tanaka H, Yoshizawa H, Gejyo F. Miura S, et al. Scand J Immunol. 2008 Apr;67(4):385-91. doi: 10.1111/j.1365-3083.2008.02083.x. Epub 2008 Feb 14. Scand J Immunol. 2008. PMID: 18282232 Free article.

5

Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage.

Koyama K, Kagamu H, Miura S, Hiura T, Miyabayashi T, Itoh R, Kuriyama H, Tanaka H, Tanaka J, Yoshizawa H, Nakata K, Gejyo F. Koyama K, et al. Among authors: miura s. Clin Cancer Res. 2008 Nov 1;14(21):6770-9. doi: 10.1158/1078-0432.CCR-08-1156. Clin Cancer Res. 2008. PMID: 18980970

6

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.

Baba J, Watanabe S, Saida Y, Tanaka T, Miyabayashi T, Koshio J, Ichikawa K, Nozaki K, Koya T, Deguchi K, Tan C, Miura S, Tanaka H, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I. Baba J, et al. Among authors: miura s. Blood. 2012 Sep 20;120(12):2417-27. doi: 10.1182/blood-2012-02-411124. Epub 2012 Jul 17. Blood. 2012. PMID: 22806892 Free article.

7

Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.

Ichikawa K, Kagamu H, Koyama K, Miyabayashi T, Koshio J, Miura S, Watanabe S, Yoshizawa H, Narita I. Ichikawa K, et al. Among authors: miura s. Vaccine. 2012 Sep 21;30(43):6190-7. doi: 10.1016/j.vaccine.2012.07.060. Epub 2012 Aug 10. Vaccine. 2012. PMID: 22889826

8

The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy.

Miura S, Watanabe S, Sato K, Makino M, Kobayashi O, Miyao H, Iwashima A, Okajima M, Tanaka J, Tanaka H, Kagamu H, Yokoyama A, Narita I, Yoshizawa H. Miura S, et al. Support Care Cancer. 2013 Sep;21(9):2575-81. doi: 10.1007/s00520-013-1835-2. Epub 2013 May 5. Support Care Cancer. 2013. PMID: 23644992 Clinical Trial.

9

DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells.

Koshio J, Kagamu H, Nozaki K, Saida Y, Tanaka T, Shoji S, Igarashi N, Miura S, Okajima M, Watanabe S, Yoshizawa H, Narita I. Koshio J, et al. Among authors: miura s. Cancer Immunol Immunother. 2013 Oct;62(10):1619-28. doi: 10.1007/s00262-013-1467-x. Epub 2013 Aug 22. Cancer Immunol Immunother. 2013. PMID: 23974721 Free PMC article.

10

DDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.

Nozaki K, Kagamu H, Shoji S, Igarashi N, Ohtsubo A, Okajima M, Miura S, Watanabe S, Yoshizawa H, Narita I. Nozaki K, et al. Among authors: miura s. PLoS One. 2014 Oct 24;9(10):e111019. doi: 10.1371/journal.pone.0111019. eCollection 2014. PLoS One. 2014. PMID: 25343452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,860 results

Search Page

Filters